Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness

This publication has 15 references indexed in Scilit:

• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  The Lancet, 2011
• The immune system in atherosclerosis
  Nature Immunology, 2011
• The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease
  Nature Reviews Cardiology, 2009
• IL-18 is involved in vascular injury in end-stage renal disease patients
  Nephrology Dialysis Transplantation, 2008
• Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?
  Blood Purification, 2008
• Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients
  Kidney International, 2007
• Insulin Resistance, Inflammation, and Blood Pressure Determine Vascular Dysfunction in CKD
  American Journal of Kidney Diseases, 2006
• Expert consensus document on arterial stiffness: methodological issues and clinical applications
  European Heart Journal, 2006
• Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals
  Circulation, 2005
• Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells
  Clinical Immunology, 2005